Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Niclosamide × Clear all

NCT02807805 2024-12-18

Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms